Diaa Mohammad Srahin
5th year Medical Student
Al-Quds University
Obstetrics & Gynecology
April/ 2018
Beit Jala Governmental Hospital (Al-Hussein)
Introduction
 A delay in conception is one of the commonest reasons
that a woman will consult her doctor.
 There is no one universal definition of subfertility, but the
commonest accepted definition is a failure to conceive after
12 months of regular unprotected intercourse.
 The incidence of subfertility is thought to affect about one
in seven heterosexual couples.
Subfertility can be classified as :
 primary, in couples who have never conceived.
 or secondary, in couples who have previously conceived.
Subfertility
Primary Secondary
The causes of subfertility can be
 male causes.
 Female causes.
 or mixed.
Subfertility
Male
causes
Female
causes
Factors
affect
both sexes
Fecundability.
This is the likelihood of conception occurring with one
cycle of appropriately timed midcycle intercourse.
 With the female partner age of 20 years, the fecundity
rate is 20%. By age 35 years, the rate drops to 10%.
Natural conception
 Eggs are thought to be fertilizable for about 12–24
hours post-ovulation, while sperm can survive in the
female reproductive tract for up to 72 hours.
 For a woman with a normal menstrual cycle of 28 days,
ovulation occurs around day 14.
 The ‘fertile window’ for women will, therefore, be
different depending on the average length of their
menstrual cycle (e.g. for a woman with a 28-day
menstrual cycle, her optimal fertile window will be
between days 12 and 15).
Epidemiologic figures
 80% of couples achieve conception within 1 year.
 25% within 1st month.
 60% within 6 months.
 75% within 9 months.
 90% within 18 months.
Factors affect the natural
conception rate
 Age
 Female >35 years, due to decline in oocyte quality & number.
 Male age is also an important factor; semen quality tends to fall in men
over the age of 50, while frequency of intercourse tends to fall in men
over the age of40.
 Smoking
 reduces fertility in female & semen quality in males.
 Alcohol
 harmful to the fetus & can affect sperm quality .
 Coital frequency
 stress & anxiety may affect libido & coital frequency & thus impact on
fertility.
 Recommended coital frequency is two to three times per week.
 Body weight
 Over or under weight can affect ovulation.
 women with a body mass index (BMI) of >29 or < 19 will have difficulty
conceiving.
 Drugs
 non-steroidal anti-inflammatory drugs (inhibit ovulation).
 chemotherapy (destroys rapidly dividing cells e.g. gametes).
 cimetidine, sulphasalazine, androgen injections (affects sperm quality).
 Occupational hazards
 exposure to chemicals and radiation adversely affects male and female
fertility.
Causes of subfertility
 The main causes of subfertility will vary in different
countries.
 In the UK subfertility is caused by :
 around 30% of subfertility is caused by male factor,
 30% female factor,
 25% unexplained
 15% both male and female or other causes.
Female causes of subfertility
Female causes
HPO axis
dysfunction
Ovarian
factors Cervical
Endometrial
factors
Tubal
ovulation
 Oogenesis occurs in the ovary from the 1st trimester of embryonic
life and completed by 28-30 weeks of gestation. (7 million
oocytes).
 The oocytes are arrested at the prophase stage of the 1st meiotic
division.
 At birth, the oocyte pool reduced to 2 million.
 By menarche, 500,000 oocyte are present.
 The ovulatory process is initiated once the HPO axis matures
and FSH and LH acquire their normal secretory pattern.
Ovarian problems
1. Central
 Pituitary insufficiency (trauma/ tumor/ congenital)
 Hypothalamic insufficiency
 Hyperprolactinemia (drug/ tumor/ empty sella)
 Luteal phase defect
2. Peripheral defects
 Gonadal dysgenesis
 Premature ovarian failure
 Ovarian tumor
 Ovarian resistance
3. Metabolic diseases.
 PCOS ( most common cause of anovulation)
 Thyroid
 Obesity
 Androgen excess (adrenal/ neoplastic)
The most common cause of anovulation is PCOS.
 Women with PCOS also suffer from menstrual
irregularities (usually oligo- or amenorrhoea).
 increased hair growth (hirsutism), acne and are more
commonly overweight.
 They also are at higher risk of diabetes and cardiovascular
disorders.
 The diagnosis of PCOS is based on a score of two out
of three of the Rotterdam criteria
Marker of ovarian reserve
 In the ovary, anti-Müllerian hormone (AMH) is produced by the
granulosa cells.
 AMH levels can be measured in blood and are shown to be
proportional to the number of small antral follicles.
 In women, serum AMH levels decrease with age and are undetectable
in the post-menopausal period.
 AMH levels represent the quantity of the ovarian follicle pool and are a
useful marker of ovarian reserve.
 AMH measurement can also be useful in the prediction of the extremes
of ovarian response to gonadotrophin stimulation for in vitro
fertilization.
Tubal blockage
 Causes:
1. previous PID such as chlamydia infection
2. Inflammatory process within the abdomen/pelvic
cavity
3. Inflammatory process as a result of surgery or
endometriosis => internal scares (adhesions).
4. History of ectopic pregnancy.
Endometrial factors
Any abnormality in the endometrium may prevent successful
implantation of embryo.
 Examples:
 Endometriosis (15% of infertile females have endometriosis)
 Uterine fibroids
 Adhesions.
 Polyps.
 Tubal ligation
 Can be surgically managed.
Uterine factors (less than 10%)
 Congenital malformations
 Submucosal fibroids
 Uterine polyps
 Asherman’s syndrome (adhesions and/or fibrosis of the
endometrium particularly but can also affect the myometrium.)
Cervical factors
 Cervicitis
 Cervical stenosis
 Mullerian duct abnormalities
 Inadequate mucus production
History and PE
Hx:
 Length of time spent trying for pregnancy.
 Any previous pregnancies.
 Coital frequency .
 Occupation.
 Menstrual history.
 Previous history of pelvic inflammatory disease .
 Previous medical and surgical history.
 Previous fertility treatment.
 Cervical smear history.
 General health – screen for history of thyroid disorders
Examination
 Signs of PCOS
 Thyroid disease signs
 Pelvic examination
 any uterine pathology such as fibroids
 Vaginal atrophy in POF
 Cervical stenosis & mucus
 General BP, pulse, height and weight
Investigations
 Check for ovarian reserve
 Check for HPO dysfunction.
 Check tubal patency:
 Hysterosalpingogram (HSG).
 Hysterocontrast synography (HyCoSy).
 Operative laparoscopy and dye test.
 HSG => radio-opaque dye => X-ray.
 HyCoSy => sono-opaque contrast =>ultrasound.
 Hysterosalpingogram (HSG)
Hysterocontrast synography (HyCoSy)
Treatment
 Ovulation induction(OI):
clomifene citrate (CC).
 Induce gonadotropin release by occupying the estrogen receptors in
the hypothalamus, thereby interfering with the normal feedback
mechanisms, increasing the release of FSH and stimulating the
ovary to produce more follicles.
 70% of women on CC will ovulate, with a pregnancy rate of 15–20%.
 There is a risk of multiple pregnancies (10%) &therefore women on CC
should be monitored by us scans to track the growth of their follicles.
 laparoscopic ovarian drilling (LOD)
 For unknown reasons, passing electrical energy through polycystic
ovaries can result in the induction of ovulation.
 it is a surgical procedure, & it’s only appropriate to offer such treatment
to who have not responded to CC.
 OI can also be performed by offering a small dose of FSH
to induce follicular growth.
 It require follicular tracking with US scan to minimize the risk of
multifollicular ovulation & risk of multiple pregnancy.
 Intrauterine insemination (IUI):
 performed by introducing a small sample of prepared sperm into the
uterine cavity with a fine uterine catheter.
 This process usually requires mild stimulation with FSH to produce 2-3
mature follicles.
 Follicular tracking is essential to avoid over or under stimulation.
 The success rate of this procedure ranges between 15 and 20 per cent in
top fertility units.
 In vitro fertilization (IVF):
 The success rate of IVF per cycle is about 30% in women <35 years of age.
 In essence, the ovaries are stimulated with FSH, and are encouraged to
produce up to 8–10 follicles.
 Induction of ovulation is then performed with an injection of hCG, after
which the eggs can be collected during an ultrasound guided procedure via a
very fine needle.
 These eggs will be fertilized in a petri dish with sperm or, if required, the
sperm can be injected directly into the egg (intracytoplasmic sperm
injection, ICSI).
 When fertilization occurs, the fertilized embryo(s) is then replaced into the
uterine cavity.
 Approximately 2 weeks after embryo transfer, a pregnancy test is performed to
check for successful implantation.
 Undergoing IVF does not preclude the patient from the normal
complications of pregnancy, such as miscarriage or ectopic
pregnancies.
 The risk of ectopic pregnancy for women who have undergone IVF is
higher than for the general population, at 3–4 per cent.
 There is the added risk of overstimulating the ovaries during an IVF
cycle.
 Patients with ovarian hyperstimulation syndrome (OHSS) present
with ascites, hugely enlarged multifollicular ovaries, pulmonary edema,
and are at risk of multiorgans failure and coagulopathy.
 These patients need to be admitted to hospital and managed under
strict protocols under the care of specialist teams.
• Video
Surgical treatment
 Offered if there is tubal blockage or endometrial
abnormality (polyp, adhesion or fibroid).
Causes
Hypothalamic-pituitary
disease
Obesity
Primary hypogonadism
Sperm transport
disorders
Defective
ejaculation
 Gonadotropin-releasing hormone (GnRH) or
gonadotropin deficiency.
 Hypogonadotropic hypogonadism
Hypothalamic-pituitary disease
1. Congenital idiopathic hypogonadotropic
hypogonadism.
Isolated gonadotropin deficiency resulting in eunuchoidism.
Eunuchoidism
Sexual
infantilism
Eunuchoid
body
Undeveloped
sexual organsNo sexual
hormones
Hypothalamic-pituitary disease
2. Acquired:
 Tumors: Pituitary macroadenomas e.g.
macroprolactinomas and nonfunctioning adenomas.
 Infiltrative disease: sarcoidosis, tuberculosis, fungal
infections.
 Vascular lesion: Pituitary infarction and carotid
aneurysm.
 Hormonal: hyperprolactinemia, estrogen excess,
glucocorticoid excess and androgen excess
Hypothalamic-pituitary disease
3. Drugs:
 Opioid-like.
 Central nervous system-acting drugs.
 Inhibit GnRH or gonadotropin secretion, resulting in secondary
hypogonadism.
 GnRH analogues
 Suppress gonadotropin secretion, as in men with prostatic carcinoma
4. Systemic or chronic illness or chronic nutritional
deficiency.
Hypothalamic-pituitary disease
Obesity
 Associated with decrease in serum sex hormone binding
globulin (SHBG).
 Low serum gonadotropin, total testosterone.
 Sperm quality may also be inversely related to BMI; > 25
Kg/m2 has lower motile cells.
Primary hypogonadism
 Testicular disorders hypergonadotropic hypogonadism.
1) Congenital disorders:
- Klinefelter's syndrome: have very small testes and almost always have
azoospermia.
- Y chromosome related defects: microdeletions in the long arm.
Testicular biopsies in these men may show germinal cell maturation arrest
or Sertoli cell-only syndrome.
- Cryptorchidism: failure of testes descent into the scrotum.
- Defective androgen receptor or synthesis
Primary hypogonadism
2) Aquired disorders:
- Varicoceles : dilatations of the pampiniform plexus of the spermatic veins in
the scrotum.
Infection: viral orchitis, especially mumps.
Due to germinal cell damage, ischemia, or the immune response to the
infection.
- Drugs: alkylating agents like cyclophosphamide, antiandrogens, cimitidine.
Through inhibiting testicular androgen production or action.
- Radiation.
- Hyperthermia.
- Testicular cancer.
Sperm transport disorders
The epididymis is an important site for sperm
maturation.
The vas deferens transports sperm from the
epididymis to the urethra.
Defective ejaculation
 Spinal cord disease or trauma.
 Sympathectomy.
 Autonomic disease.
 Erectile dysfunction.
 Mechanical obstruction.
 Premature ejaculation.
History and PE
History:
 Length of time spent trying for pregnancy.
 Fathered any previous pregnancies.
 History of mumps or measles
 History of testicular trauma, surgery to testis
 Occupation
 Medical and surgical history
Physical examination:
 Testicular examination : testicular volume, consistency,
masses, absence of vas deferens, varicocele, evidence of
surgical scars.
Investigations
Semen analysis
 It should be performed after the patients have
abstained from sexual intercourse for 3–4 days.
 Two abnormal test results are required to diagnose
male subfertility.
normal parameters for semen analysis (WHO criteria)
volume >2ml
pH >7.2
Sperm concentration >20 million/ml
Total sperm number >40 million/ ejaculate
motility >50% grade a & b
morphology >30% normal forms
 For men with a very low sperm count or azoospermia, it is important
to check their testosterone levels (low levels suggest a production
impairment) and LH/FSH.
 It is also important to screen for the cystic fibrosis (CF) mutation as
a congenital bilateral absence of the vas deferens (CBAVD) is a
minor variant of cystic fibrosis.
 Karyotyping is also offered as there may be Y chromosome deletion
defects.
Surgical sperm retrieval
 Where the sperm quality is low but sperm are present, ICSI is
required to help achieve a pregnancy.
 However, in the absence of naturally ejaculated sperm, patients will
have to undergo surgical sperm retrieval (SSR).
 SSR can be performed under sedation or general anaesthetic.
 A fine needle is inserted into the epididymis or the testicular tissue to
obtain sperm or testicular tissue with sperm, respectively.
 The retrieved sperm can then be cryopreserved or injected into the
oocyte as part of a fresh IVF/ICSI cycle.
Cryopreservation of gametes
 Sperm or oocyte can be cryopreserved for later use.
 Often this process is very useful in preserving fertility for
patients undergoing chemo/radiation therapy for cancer.
 Currently, the pregnancy rate for thawed sperm/egg in top
fertility centers is very near to that of normal IVF cycles.
 This process can also be used for storage of gametes from
donors who wish to donate their sperm or eggs for altruistic
reasons to help couples with fertility problems.
Male and Female Subfertility

Male and Female Subfertility

  • 1.
    Diaa Mohammad Srahin 5thyear Medical Student Al-Quds University Obstetrics & Gynecology April/ 2018 Beit Jala Governmental Hospital (Al-Hussein)
  • 2.
    Introduction  A delayin conception is one of the commonest reasons that a woman will consult her doctor.  There is no one universal definition of subfertility, but the commonest accepted definition is a failure to conceive after 12 months of regular unprotected intercourse.  The incidence of subfertility is thought to affect about one in seven heterosexual couples.
  • 3.
    Subfertility can beclassified as :  primary, in couples who have never conceived.  or secondary, in couples who have previously conceived. Subfertility Primary Secondary
  • 4.
    The causes ofsubfertility can be  male causes.  Female causes.  or mixed. Subfertility Male causes Female causes Factors affect both sexes
  • 5.
    Fecundability. This is thelikelihood of conception occurring with one cycle of appropriately timed midcycle intercourse.  With the female partner age of 20 years, the fecundity rate is 20%. By age 35 years, the rate drops to 10%.
  • 7.
    Natural conception  Eggsare thought to be fertilizable for about 12–24 hours post-ovulation, while sperm can survive in the female reproductive tract for up to 72 hours.  For a woman with a normal menstrual cycle of 28 days, ovulation occurs around day 14.  The ‘fertile window’ for women will, therefore, be different depending on the average length of their menstrual cycle (e.g. for a woman with a 28-day menstrual cycle, her optimal fertile window will be between days 12 and 15).
  • 8.
    Epidemiologic figures  80%of couples achieve conception within 1 year.  25% within 1st month.  60% within 6 months.  75% within 9 months.  90% within 18 months.
  • 9.
    Factors affect thenatural conception rate  Age  Female >35 years, due to decline in oocyte quality & number.  Male age is also an important factor; semen quality tends to fall in men over the age of 50, while frequency of intercourse tends to fall in men over the age of40.  Smoking  reduces fertility in female & semen quality in males.  Alcohol  harmful to the fetus & can affect sperm quality .
  • 10.
     Coital frequency stress & anxiety may affect libido & coital frequency & thus impact on fertility.  Recommended coital frequency is two to three times per week.  Body weight  Over or under weight can affect ovulation.  women with a body mass index (BMI) of >29 or < 19 will have difficulty conceiving.  Drugs  non-steroidal anti-inflammatory drugs (inhibit ovulation).  chemotherapy (destroys rapidly dividing cells e.g. gametes).  cimetidine, sulphasalazine, androgen injections (affects sperm quality).  Occupational hazards  exposure to chemicals and radiation adversely affects male and female fertility.
  • 12.
    Causes of subfertility The main causes of subfertility will vary in different countries.  In the UK subfertility is caused by :  around 30% of subfertility is caused by male factor,  30% female factor,  25% unexplained  15% both male and female or other causes.
  • 15.
    Female causes ofsubfertility Female causes HPO axis dysfunction Ovarian factors Cervical Endometrial factors Tubal
  • 16.
    ovulation  Oogenesis occursin the ovary from the 1st trimester of embryonic life and completed by 28-30 weeks of gestation. (7 million oocytes).  The oocytes are arrested at the prophase stage of the 1st meiotic division.  At birth, the oocyte pool reduced to 2 million.  By menarche, 500,000 oocyte are present.  The ovulatory process is initiated once the HPO axis matures and FSH and LH acquire their normal secretory pattern.
  • 18.
    Ovarian problems 1. Central Pituitary insufficiency (trauma/ tumor/ congenital)  Hypothalamic insufficiency  Hyperprolactinemia (drug/ tumor/ empty sella)  Luteal phase defect 2. Peripheral defects  Gonadal dysgenesis  Premature ovarian failure  Ovarian tumor  Ovarian resistance 3. Metabolic diseases.  PCOS ( most common cause of anovulation)  Thyroid  Obesity  Androgen excess (adrenal/ neoplastic)
  • 19.
    The most commoncause of anovulation is PCOS.  Women with PCOS also suffer from menstrual irregularities (usually oligo- or amenorrhoea).  increased hair growth (hirsutism), acne and are more commonly overweight.  They also are at higher risk of diabetes and cardiovascular disorders.
  • 20.
     The diagnosisof PCOS is based on a score of two out of three of the Rotterdam criteria
  • 21.
    Marker of ovarianreserve  In the ovary, anti-Müllerian hormone (AMH) is produced by the granulosa cells.  AMH levels can be measured in blood and are shown to be proportional to the number of small antral follicles.  In women, serum AMH levels decrease with age and are undetectable in the post-menopausal period.  AMH levels represent the quantity of the ovarian follicle pool and are a useful marker of ovarian reserve.  AMH measurement can also be useful in the prediction of the extremes of ovarian response to gonadotrophin stimulation for in vitro fertilization.
  • 22.
    Tubal blockage  Causes: 1.previous PID such as chlamydia infection 2. Inflammatory process within the abdomen/pelvic cavity 3. Inflammatory process as a result of surgery or endometriosis => internal scares (adhesions). 4. History of ectopic pregnancy.
  • 23.
    Endometrial factors Any abnormalityin the endometrium may prevent successful implantation of embryo.  Examples:  Endometriosis (15% of infertile females have endometriosis)  Uterine fibroids  Adhesions.  Polyps.  Tubal ligation  Can be surgically managed.
  • 24.
    Uterine factors (lessthan 10%)  Congenital malformations  Submucosal fibroids  Uterine polyps  Asherman’s syndrome (adhesions and/or fibrosis of the endometrium particularly but can also affect the myometrium.)
  • 25.
    Cervical factors  Cervicitis Cervical stenosis  Mullerian duct abnormalities  Inadequate mucus production
  • 26.
    History and PE Hx: Length of time spent trying for pregnancy.  Any previous pregnancies.  Coital frequency .  Occupation.  Menstrual history.  Previous history of pelvic inflammatory disease .  Previous medical and surgical history.  Previous fertility treatment.  Cervical smear history.  General health – screen for history of thyroid disorders
  • 27.
    Examination  Signs ofPCOS  Thyroid disease signs  Pelvic examination  any uterine pathology such as fibroids  Vaginal atrophy in POF  Cervical stenosis & mucus  General BP, pulse, height and weight
  • 28.
    Investigations  Check forovarian reserve  Check for HPO dysfunction.  Check tubal patency:  Hysterosalpingogram (HSG).  Hysterocontrast synography (HyCoSy).  Operative laparoscopy and dye test.  HSG => radio-opaque dye => X-ray.  HyCoSy => sono-opaque contrast =>ultrasound.
  • 29.
  • 30.
  • 31.
    Treatment  Ovulation induction(OI): clomifenecitrate (CC).  Induce gonadotropin release by occupying the estrogen receptors in the hypothalamus, thereby interfering with the normal feedback mechanisms, increasing the release of FSH and stimulating the ovary to produce more follicles.  70% of women on CC will ovulate, with a pregnancy rate of 15–20%.  There is a risk of multiple pregnancies (10%) &therefore women on CC should be monitored by us scans to track the growth of their follicles.
  • 32.
     laparoscopic ovariandrilling (LOD)  For unknown reasons, passing electrical energy through polycystic ovaries can result in the induction of ovulation.  it is a surgical procedure, & it’s only appropriate to offer such treatment to who have not responded to CC.  OI can also be performed by offering a small dose of FSH to induce follicular growth.  It require follicular tracking with US scan to minimize the risk of multifollicular ovulation & risk of multiple pregnancy.
  • 33.
     Intrauterine insemination(IUI):  performed by introducing a small sample of prepared sperm into the uterine cavity with a fine uterine catheter.  This process usually requires mild stimulation with FSH to produce 2-3 mature follicles.  Follicular tracking is essential to avoid over or under stimulation.  The success rate of this procedure ranges between 15 and 20 per cent in top fertility units.
  • 34.
     In vitrofertilization (IVF):  The success rate of IVF per cycle is about 30% in women <35 years of age.  In essence, the ovaries are stimulated with FSH, and are encouraged to produce up to 8–10 follicles.  Induction of ovulation is then performed with an injection of hCG, after which the eggs can be collected during an ultrasound guided procedure via a very fine needle.  These eggs will be fertilized in a petri dish with sperm or, if required, the sperm can be injected directly into the egg (intracytoplasmic sperm injection, ICSI).  When fertilization occurs, the fertilized embryo(s) is then replaced into the uterine cavity.  Approximately 2 weeks after embryo transfer, a pregnancy test is performed to check for successful implantation.
  • 35.
     Undergoing IVFdoes not preclude the patient from the normal complications of pregnancy, such as miscarriage or ectopic pregnancies.  The risk of ectopic pregnancy for women who have undergone IVF is higher than for the general population, at 3–4 per cent.  There is the added risk of overstimulating the ovaries during an IVF cycle.  Patients with ovarian hyperstimulation syndrome (OHSS) present with ascites, hugely enlarged multifollicular ovaries, pulmonary edema, and are at risk of multiorgans failure and coagulopathy.  These patients need to be admitted to hospital and managed under strict protocols under the care of specialist teams.
  • 37.
  • 38.
    Surgical treatment  Offeredif there is tubal blockage or endometrial abnormality (polyp, adhesion or fibroid).
  • 40.
  • 41.
     Gonadotropin-releasing hormone(GnRH) or gonadotropin deficiency.  Hypogonadotropic hypogonadism Hypothalamic-pituitary disease
  • 42.
    1. Congenital idiopathichypogonadotropic hypogonadism. Isolated gonadotropin deficiency resulting in eunuchoidism. Eunuchoidism Sexual infantilism Eunuchoid body Undeveloped sexual organsNo sexual hormones Hypothalamic-pituitary disease
  • 43.
    2. Acquired:  Tumors:Pituitary macroadenomas e.g. macroprolactinomas and nonfunctioning adenomas.  Infiltrative disease: sarcoidosis, tuberculosis, fungal infections.  Vascular lesion: Pituitary infarction and carotid aneurysm.  Hormonal: hyperprolactinemia, estrogen excess, glucocorticoid excess and androgen excess Hypothalamic-pituitary disease
  • 44.
    3. Drugs:  Opioid-like. Central nervous system-acting drugs.  Inhibit GnRH or gonadotropin secretion, resulting in secondary hypogonadism.  GnRH analogues  Suppress gonadotropin secretion, as in men with prostatic carcinoma 4. Systemic or chronic illness or chronic nutritional deficiency. Hypothalamic-pituitary disease
  • 45.
    Obesity  Associated withdecrease in serum sex hormone binding globulin (SHBG).  Low serum gonadotropin, total testosterone.  Sperm quality may also be inversely related to BMI; > 25 Kg/m2 has lower motile cells.
  • 46.
    Primary hypogonadism  Testiculardisorders hypergonadotropic hypogonadism. 1) Congenital disorders: - Klinefelter's syndrome: have very small testes and almost always have azoospermia. - Y chromosome related defects: microdeletions in the long arm. Testicular biopsies in these men may show germinal cell maturation arrest or Sertoli cell-only syndrome. - Cryptorchidism: failure of testes descent into the scrotum. - Defective androgen receptor or synthesis
  • 47.
    Primary hypogonadism 2) Aquireddisorders: - Varicoceles : dilatations of the pampiniform plexus of the spermatic veins in the scrotum. Infection: viral orchitis, especially mumps. Due to germinal cell damage, ischemia, or the immune response to the infection. - Drugs: alkylating agents like cyclophosphamide, antiandrogens, cimitidine. Through inhibiting testicular androgen production or action. - Radiation. - Hyperthermia. - Testicular cancer.
  • 48.
    Sperm transport disorders Theepididymis is an important site for sperm maturation. The vas deferens transports sperm from the epididymis to the urethra.
  • 49.
    Defective ejaculation  Spinalcord disease or trauma.  Sympathectomy.  Autonomic disease.  Erectile dysfunction.  Mechanical obstruction.  Premature ejaculation.
  • 50.
    History and PE History: Length of time spent trying for pregnancy.  Fathered any previous pregnancies.  History of mumps or measles  History of testicular trauma, surgery to testis  Occupation  Medical and surgical history
  • 51.
    Physical examination:  Testicularexamination : testicular volume, consistency, masses, absence of vas deferens, varicocele, evidence of surgical scars.
  • 52.
    Investigations Semen analysis  Itshould be performed after the patients have abstained from sexual intercourse for 3–4 days.  Two abnormal test results are required to diagnose male subfertility. normal parameters for semen analysis (WHO criteria) volume >2ml pH >7.2 Sperm concentration >20 million/ml Total sperm number >40 million/ ejaculate motility >50% grade a & b morphology >30% normal forms
  • 53.
     For menwith a very low sperm count or azoospermia, it is important to check their testosterone levels (low levels suggest a production impairment) and LH/FSH.  It is also important to screen for the cystic fibrosis (CF) mutation as a congenital bilateral absence of the vas deferens (CBAVD) is a minor variant of cystic fibrosis.  Karyotyping is also offered as there may be Y chromosome deletion defects.
  • 54.
    Surgical sperm retrieval Where the sperm quality is low but sperm are present, ICSI is required to help achieve a pregnancy.  However, in the absence of naturally ejaculated sperm, patients will have to undergo surgical sperm retrieval (SSR).  SSR can be performed under sedation or general anaesthetic.  A fine needle is inserted into the epididymis or the testicular tissue to obtain sperm or testicular tissue with sperm, respectively.  The retrieved sperm can then be cryopreserved or injected into the oocyte as part of a fresh IVF/ICSI cycle.
  • 55.
    Cryopreservation of gametes Sperm or oocyte can be cryopreserved for later use.  Often this process is very useful in preserving fertility for patients undergoing chemo/radiation therapy for cancer.  Currently, the pregnancy rate for thawed sperm/egg in top fertility centers is very near to that of normal IVF cycles.  This process can also be used for storage of gametes from donors who wish to donate their sperm or eggs for altruistic reasons to help couples with fertility problems.

Editor's Notes

  • #22 Measures of ovarian reserve. These tests help predict whether a woman will respond to ovarian stimulation or whether it would be best to proceed directly to in-vitro fertilization (IVF). • Day 3 FSH is the most commonly used test for ORT. FSH levels are expected to be low due to the feedback of estrogen from the stimulated follicles. An increase in FSH level occurs if there is follicle depletion. • Anti-Mullerian hormone (AMH). This glycoprotein is produced exclusively by small antral ovarian follicles and is therefore a direct measure of the follicular pool. As the number of ovarian follicles declines with age, AMH concentrations will decline. • Antral follicle count (AFC) is the total number of follicles measuring 2-10 mm in diameter that are observed during an early follicular phase transvaginal sonogram. The number of AF correlates with the size of the remaining follicle pool retrieved by ovarian stimulation. AFC typically declines with age.
  • #38 https://www.youtube.com/watch?v=eO27B563GYg